Search Ontology:
ChEBI

PF-3758309

Term ID
CHEBI:93751
Synonyms
  • N-[(1S)-2-(dimethylamino)-1-phenylethyl]-6,6-dimethyl-3-[(2-methylthieno[3,2-d]pyrimidin-4-yl)amino]-4,6-dihydropyrrolo[3,4-c]pyrazole-5(1H)-carboxamide
  • PF 309
  • PF 3758309
  • PF-03758309
  • PF-309
  • PF309
  • PF3758309
Definition
A member of the class of thienopyrimidines that is thieno[3,2-d]pyrimidine substituted by methyl and (5-{[(1S)-2-(dimethylamino)-1-phenylethyl]carbamoyl}-6,6-dimethyl-1,4,5,6-tetrahydropyrrolo[3,4-c]pyrazol-3-yl)amino groups at positions 2 and 4, respectively. It is a potent inhibitor of PAK4 and inhibits the growth of multiple human tumor xenografts.
References
  • cas:898044-15-0
  • drugbank:DB11775
  • lincs.smallmolecule:LSM-4254
  • pdb-ccd:7KC
  • pubmed:20439741
  • pubmed:23524533
  • pubmed:23543898
  • pubmed:24204982
  • pubmed:24366569
  • pubmed:24432870
  • pubmed:25640698
  • pubmed:29048629
  • pubmed:29191878
  • pubmed:30455231
  • pubmed:31312349
  • pubmed:31595158
  • pubmed:32469945
  • pubmed:32829006
  • pubmed:33414491
  • pubmed:33987822
  • pubmed:35401439
  • pubmed:35939342
  • pubmed:36240067
  • pubmed:36671485
  • pubmed:37258566
  • pubmed:37564209
  • pubmed:37568037
  • pubmed:37864885
  • pubmed:38336988
  • pubmed:38885414
Ontology
ChEBI  ( EBI )
Relationships
Phenotype
Phenotype resulting from PF-3758309
Phenotype where environments contain PF-3758309
Phenotype modified by environments containing PF-3758309
Phenotype affecting PF-3758309
Human Disease Model